Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, United kingdom.
J Clin Endocrinol Metab. 2012 Nov;97(11):E2188-93. doi: 10.1210/jc.2012-1980. Epub 2012 Aug 31.
Silver-Russell syndrome (SRS; online inheritance in man 180860) is a low-birth-weight syndrome characterized by postnatal growth restriction and variable dysmorphic features. Although maternal uniparental disomy (UPD) of chromosome 7 and hypomethylation of H19 have been reported in up to 50% of all cases, no unifying mechanism is apparent.
Ten patients and their parents were studied using the Illumina GoldenGate methylation array and the Illumina 370K HumHap single-nucleotide polymorphism array to identify aberrations in DNA methylation as well as genomic changes including copy number changes and uniparental disomy events.
We found evidence of UPD events outside chromosome 7 in all patients. In up to 30% of patients with SRS, DNA methylation changes occur in imprinted gene loci outside 11p15.5 (PEG3, PLAGL1, and GRB10), not previously consistently linked with SRS. Furthermore, hypermethylation of GRB10 was associated with increased mRNA expression. In addition, 20% of patients appear to have DNA methylation abnormalities within multiple loci. Not all the imprinted loci with methylation defects were affected directly by UPD.
The association of widespread UPD associated with abnormal methylation and mRNA expression in imprinted genes in SRS is consistent with the concept of UPD as an initial genomic abnormality leading to unstable DNA methylation within the regulatory network of imprinted genes. Furthermore, disruption of any one of these genes may contribute to the heterogeneous clinical spectrum of SRS.
银- Russell 综合征(SRS;在线男性 180860 遗传)是一种低出生体重综合征,其特征为出生后生长受限和可变的发育异常。尽管多达 50%的病例报道了母体单亲二体(UPD)的 7 号染色体和 H19 的低甲基化,但目前还没有明显的统一机制。
使用 Illumina GoldenGate 甲基化阵列和 Illumina 370K HumHap 单核苷酸多态性阵列研究了 10 名患者及其父母,以鉴定 DNA 甲基化异常以及基因组变化,包括拷贝数变化和单亲二体事件。
我们发现所有患者均存在 7 号染色体以外的 UPD 事件证据。在多达 30%的 SRS 患者中,印迹基因座(11p15.5 以外的 PEG3、PLAGL1 和 GRB10)的 DNA 甲基化变化发生在外显子,这些基因座以前与 SRS 没有一致的联系。此外,GRB10 的高甲基化与 mRNA 表达增加有关。此外,20%的患者似乎存在多个基因座的 DNA 甲基化异常。并非所有具有甲基化缺陷的印迹基因座都受到 UPD 的直接影响。
SRS 中广泛的 UPD 与印迹基因中异常甲基化和 mRNA 表达相关联,这与 UPD 作为导致印迹基因调控网络内不稳定 DNA 甲基化的初始基因组异常的概念一致。此外,这些基因中的任何一个的破坏都可能导致 SRS 的异质临床谱。